Glycomics and Glycobiology Market - 2024-2031
Glycomics and Glycobiology Marketis is growing with a CAGR of 17.30% during the forecast period 2026-2035.
The Glycomics and Glycobiology Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Glycomics and Glycobiology Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product
Both primary and secondary data sources have been used in the global Glycomics and Glycobiology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
The Glycomics and Glycobiology Market emerges as a key focus in DataM Intelligence latest in-depth analysis, where seasoned researchers harness advanced data analytics and strategic foresight to deliver unparalleled market intelligence. This insightful report meticulously explores the competitive landscape, profiling key players and their forward-thinking innovations in product development, pricing strategies, financial metrics, and global expansion initiatives. By uncovering the driving forces, market dynamics, and disruptive trends shaping the future, this research equips industry stakeholders with the actionable insights needed to make informed decisions in an increasingly dynamic and competitive environment.
A Glycomics and Glycobiology Market is a data-driven software solution that collects, integrates, analyzes, and visualizes customer data across various touchpoints to generate actionable insights. These platforms help businesses understand customer behaviors, preferences, and purchasing patterns in real time, enabling personalized marketing, enhanced customer engagement, and data-driven decision-making.
By Product
- Enzymes*
- Glycosidases & Neuramidases
- Glycosyltransferases & Sialytransferases
- Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)
- Instruments
- Mass Spectrometry Instruments
- Chromatography Instruments
- Arrays
- Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns)
- Kits
- Glycan Releasing Kits
- Glycan Labeling Kits
- Glycan Purification Kits
- Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits)
- Carbohydrates
- Oligosaccharides
- Monosaccharides
- Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides)
- Reagents & Chemicals
- Drug Discovery & Development*
- Disease Diagnostics
- Other Applications (virology, cell biology, and microbiology)
- Hospitals*
- Academic Research Institutes
- Pharmaceutical and Biotechnology Companies
- Clinical Laboratories
- North America (U.S., Canada, Mexico)
- Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
- Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
- South America (Colombia, Brazil, Argentina, Rest of South America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
- Go-to-market Strategy.
- Neutral perspective on the market performance.
- Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.
- Customized regional/country reports as per request and country level analysis.
- Potential & niche segments and regions exhibiting promising growth covered.
- Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).
Both primary and secondary data sources have been used in the global Glycomics and Glycobiology Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
1. METHODOLOGY AND SCOPE
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Product
3.2. Market Snippet by Application
3.3. Market Snippet by End-User
3.4. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising number of government's initiatives to increase funding for R&D
4.1.2. Restraints:
4.1.2.1. High cost of tools
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PEST Analysis
5.7. Reimbursement
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Enzymes*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.2.3. Glycosidases & Neuramidases
7.2.4. Glycosyltransferases & Sialytransferases
7.2.5. Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)
7.3. Instruments
7.3.1. Mass Spectrometry Instruments
7.3.2. Chromatography Instruments
7.3.3. Arrays
7.3.4. Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns)
7.4. Kits
7.4.1. Glycan Releasing Kits
7.4.2. Glycan Labeling Kits
7.4.3. Glycan Purification Kits
7.4.4. Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits)
7.5. Carbohydrates
7.5.1. Oligosaccharides
7.5.2. Monosaccharides
7.5.3. Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides)
7.6. Reagents & Chemicals
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Drug Discovery & Development*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Disease Diagnostics
8.4. Other Applications (virology, cell biology, and microbiology)
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
9.1.2. Market Attractiveness Index, By End-User Segment
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Academic Research Institutes
9.4. Pharmaceutical and Biotechnology Companies
9.5. Clinical Laboratories
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Key Developments and Strategies
11.3. Company Share Analysis
11.4. Product Benchmarking
11.5. Key Companies to Watch
11.6. Company with disruptive technology
12. COMPANY PROFILES
12.1. Merck KGaA*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Agilent Technologies
12.3. Thermo Fisher Scientific
12.4. New England Biolabs
12.5. Shimadzu Corporation
12.6. Waters Corporation
12.7. Asparia Glycomics S.L
12.8. Bruker Corporation
12.9. Chemily Glycoscience
12.10. Dextra Laboratories (*LIST NOT EXHAUSTIVE*)
13. DATAM INTELLIGENCE
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. MARKET DEFINITION AND OVERVIEW
3. EXECUTIVE SUMMARY
3.1. Market Snippet by Product
3.2. Market Snippet by Application
3.3. Market Snippet by End-User
3.4. Market Snippet by Region
4. MARKET DYNAMICS
4.1. Market Impacting Factors
4.1.1. Drivers
4.1.1.1. Rising number of government's initiatives to increase funding for R&D
4.1.2. Restraints:
4.1.2.1. High cost of tools
4.1.3. Opportunity
4.1.4. Impact Analysis
5. INDUSTRY ANALYSIS
5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs
5.6. PEST Analysis
5.7. Reimbursement
6. COVID-19 ANALYSIS
6.1. Analysis of Covid-19 on the Market
6.1.1. Before COVID-19 Market Scenario
6.1.2. Present COVID-19 Market Scenario
6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion
7. BY PRODUCT
7.1. Introduction
7.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
7.1.2. Market Attractiveness Index, By Product
7.2. Enzymes*
7.2.1. Introduction
7.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
7.2.3. Glycosidases & Neuramidases
7.2.4. Glycosyltransferases & Sialytransferases
7.2.5. Other Enzymes (Carbohydrate kinases, carbohydrate sulfotransferases, protein sulfotransferases, and sulfatases)
7.3. Instruments
7.3.1. Mass Spectrometry Instruments
7.3.2. Chromatography Instruments
7.3.3. Arrays
7.3.4. Other Instruments (electrophoresis instruments, NMR instruments, and HPLC columns)
7.4. Kits
7.4.1. Glycan Releasing Kits
7.4.2. Glycan Labeling Kits
7.4.3. Glycan Purification Kits
7.4.4. Other Kits (glycan detection kits, glycan enrichment kits, and glycan sample preparation kits)
7.5. Carbohydrates
7.5.1. Oligosaccharides
7.5.2. Monosaccharides
7.5.3. Other Carbohydrates (rare sugars, glycoproteins, glycolipids, and glycol peptides)
7.6. Reagents & Chemicals
8. BY APPLICATION
8.1. Introduction
8.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
8.1.2. Market Attractiveness Index, By Application
8.2. Drug Discovery & Development*
8.2.1. Introduction
8.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
8.3. Disease Diagnostics
8.4. Other Applications (virology, cell biology, and microbiology)
9. BY END-USER
9.1. Introduction
9.1.1. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User Segment
9.1.2. Market Attractiveness Index, By End-User Segment
9.2. Hospitals*
9.2.1. Introduction
9.2.2. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028
9.3. Academic Research Institutes
9.4. Pharmaceutical and Biotechnology Companies
9.5. Clinical Laboratories
10. BY REGION
10.1. Introduction
10.1.1. Market Size Analysis, US$ Million, 2018-2028 and Y-o-Y Growth Analysis (%), 2020-2028, By Region
10.1.2. Market Attractiveness Index, By Region
10.2. North America
10.2.1. Introduction
10.2.2. Key Region-Specific Dynamics
10.2.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.2.6.1. U.S.
10.2.6.2. Canada
10.2.6.3. Mexico
10.3. Europe
10.3.1. Introduction
10.3.2. Key Region-Specific Dynamics
10.3.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.3.6.1. Germany
10.3.6.2. U.K.
10.3.6.3. France
10.3.6.4. Italy
10.3.6.5. Spain
10.3.6.6. Rest of Europe
10.4. South America
10.4.1. Introduction
10.4.2. Key Region-Specific Dynamics
10.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.4.6.1. Brazil
10.4.6.2. Argentina
10.4.6.3. Rest of South America
10.5. Asia Pacific
10.5.1. Introduction
10.5.2. Key Region-Specific Dynamics
10.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
10.5.6.1. China
10.5.6.2. India
10.5.6.3. Japan
10.5.6.4. Australia
10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
10.6.1. Introduction
10.6.2. Key Region-Specific Dynamics
10.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End-User
11. COMPETITIVE LANDSCAPE
11.1. Competitive Scenario
11.2. Key Developments and Strategies
11.3. Company Share Analysis
11.4. Product Benchmarking
11.5. Key Companies to Watch
11.6. Company with disruptive technology
12. COMPANY PROFILES
12.1. Merck KGaA*
12.1.1. Company Overview
12.1.2. Product Portfolio and Description
12.1.3. Key Highlights
12.1.4. Financial Overview
12.2. Agilent Technologies
12.3. Thermo Fisher Scientific
12.4. New England Biolabs
12.5. Shimadzu Corporation
12.6. Waters Corporation
12.7. Asparia Glycomics S.L
12.8. Bruker Corporation
12.9. Chemily Glycoscience
12.10. Dextra Laboratories (*LIST NOT EXHAUSTIVE*)
13. DATAM INTELLIGENCE
13.1. Appendix
13.2. About Us and Services
13.3. Contact Us
